Erica Rogers - Jul 11, 2023 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
President and CEO, Director
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Jul 11, 2023
Transactions value $
-$29,960
Form type
4
Date filed
7/13/2023, 06:34 PM
Previous filing
Jun 12, 2023
Next filing
Jun 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $1.6K +1K +0.37% $1.60* 271K Jul 11, 2023 Direct F1
transaction SILK Common Stock Sale -$31.6K -1K -0.37% $31.56 270K Jul 11, 2023 Direct F1
holding SILK Common Stock 83.8K Jul 11, 2023 Trustees of The Surace/Rogers Family Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -1K -6.82% $0.00 13.7K Jul 11, 2023 Common Stock 1K $1.60 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on August 8, 2022, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2 These shares are held directly by Kevin J. Surace and Erica J. Rogers, as Trustees of The Surace Rogers Family Trust.
F3 All of the shares subject to the option are fully vested and exercisable as of the date hereof.